Insights
Your Business, Our Solutions.
Analysis and commentary on Kenyan law as it is practised: corporate, IP, regulatory, disputes and the industries we serve. Written by the advocates who do the work.
Regulatory & ComplianceCross-Border Licensing Deals: What Multinational Pharma Should Know About Kenyan Contract LawWhen a multinational pharmaceutical company licenses a molecule, a manufacturing process, or a product dossier into Kenya, or…8 Sep 2026
Corporate & CommercialListing on NSE GEMS: A Capital-Raising Option for Kenyan Health-Tech CompaniesKenyan health-tech companies raising growth capital usually think first of venture capital or bank debt. A third route…3 Sep 2026
Regulatory & ComplianceManufacturing and Supply Agreements for Pharmaceutical Companies Operating in KenyaMost pharmaceutical products sold in Kenya are not made by the company whose name appears on the box.…3 Sep 2026
Regulatory & ComplianceFrom Trial to Market: Structuring Sponsor-Site Clinical Trial Agreements Under Kenyan LawA sponsor-site clinical trial agreement is the contract that makes a clinical trial legally workable in Kenya. It…3 Sep 2026
Corporate & CommercialIP Due Diligence in Life Sciences Deals: What Kenyan Investors and Acquirers Should CheckIP due diligence in a Kenyan life sciences deal is not a paperwork exercise. Biotech, pharma, medical device…3 Sep 2026
Corporate & CommercialMergers and Acquisitions in Kenya’s Healthcare Sector: A Legal Due Diligence GuideMergers and acquisitions in Kenya's healthcare sector move through more regulatory checkpoints than a typical commercial deal. A…3 Sep 2026
Corporate & CommercialVenture Financing for Kenyan Health-Tech Startups: Key Terms Founders Should UnderstandA Kenyan health-tech founder negotiating a first venture round is usually focused on valuation and board composition. The…3 Sep 2026
Corporate & CommercialStructuring Licensing and Collaboration Agreements for Kenyan Biotech and Pharma CompaniesA licensing or collaboration agreement between a Kenyan biotech company and a foreign partner is not just a…3 Sep 2026
Regulatory & ComplianceGlobal Drug Pricing Pressure and Kenya’s Access-to-Medicines DebateWashington's push for most-favoured-nation drug pricing is reshaping how global pharmaceutical manufacturers think about pricing everywhere, including in…3 Sep 2026 Talk to usNot sure where to start?Tell us what you need and we will point you to the right person.Get in touch